|
| |
Hangzhou Adamerck Pharmlabs Inc. is a wholly foreign owned enterprise which founded by Chinese American doctor in 2000 , and mainly engaged in research and development of new drugs , especially drugs with independent intellectual property rights . So far, Adamerck has obtained 36 patents and 4 high-tech achievements,which shows a strong bility in innovation. As with the new drug’s bringing into production and listing into market, Adamerck will become a innovative pharmaceutical enterprise encompassing technology,industry and trade.
Adamerck owns an excellent team specialized in pharmaceutical synthesis , chiral pharmaceuticals development, pharmaceutical analysis , pharmacological research , preparation technique and program management. And we are also getting ready to setup another team especial for sale and manufacture. Furthermore it has a strong technical support which made up of knowledgeable and experienced talents ,such as consultants of clinical medicine and pharmaceutical ,international students,etc. we have established strategic partnerships with many domestic and foreign companies, devoting to establish screening platforms of synthetic and natural pharmaceuticals, innovation platforms of preparation technologies and medicines. On the basis of preparation innovation platform , two new drug formulations got breakthrough.and acquired.a series of patent technology achievements. Clinical declaration for them are preparing now. Adamerck applies itself into the drug developing and screening, and also has obtained a gratifying achievements from the original innovations. Three of Adamerck’s NCEs have shown superior activity in pharmacokinetic and pharmacodynamic tests. AM0498 is one of them for which Adamerck is now planning to apply for clinic in 2011. In addition, PG49088 which invented by Adamerck’s chief researcher has entered Phase III clinical trial in the United State,and a number of great potential compounds are now in screening. |
|
| |
Meanwhile, we form a platforms of preparation with the purpose of increasing the bioavailability. There are 2 new dosage form, in which we have yet maked a breakthrough. As gained a series of achievement on propietary technology, we will take them apply for clinic.
Since 2001, Adamerck’s innovative researches have aquired lots of government financial supports,,e.g. Foreign Student Venture Funds, Venture Seed Funds, Medicine Development Fund , and Innovation Funds.
So far, Adamerck has won the acclaim of peers with the strong technology strength, the excellent innovative product, the high efficiency of resource integration, as well as the good-faith . Upholding the principle of mutual benefit and win-win, Adamerck hopes to co-created a better future with any peers at home and abroad.
Adamerck’s mission:
No renovation, no powerful national pharmaceutical industry. Mission of Adamerck is what to initiate a way of new drug development with Chinese characteristics. “More excellence we manufact, More benefits on society we provide!”
Adamerck’s strategy
Thus, it exists a considerable disparity in fund input between China and foreign countries. However, we must realize the point that new drug develop belongs to innovation driven, which means it possess an outstanding characteristic that developing depends on intelligence. New drug innovation does not absolutely rest with fund.
Therefore, Adamerck’s strategy is that: play the adventage on intelligence and technique, discover and improve the imperfection of the marketed new drug, and transform them to a better patent agent, so as to benefit mankind. As in the following, we can control the cost on drugs of me-too and me-better, and turn the tables from insufficient of fund by rolling development. Then after a certain financial accumulation, initiate the innovation of brand chemical entity drug.
Growth trajectory of Adamerck:
As is well kown that the way to drug innovation is formidable with hard project approval and frail hope in success, and that is why a lot of enterprises dare not show any insterest in.
However, Adamerck carries forward the so called dauntless and heroic spirit, relies on the limited self-financing, insists on its way to innovation, and accomplishes the mission impossible.
Way to innovation is lonely, just as the name of Adamerck(its Chinese name contains a meaning of lonely), whose develop team has being worked in this research area consistently. From a small-scale company in 2000 which is consisted of only 3 people, Adamerck now has turned into a morden pharmaceutical development enterprise possessing a office and lab building with floor sapce of 7000 m2, a excellent develop team and a number of develop achievement.
The aim of Adamerck is “ innovate to confer benefits on society”.
Working towards our objective, so far we have conpleted more than 150 applications of traditional Chinese medicine and western medicine, and recieves over 40 new drug certificates. Meanwhile, we have succeed in accomplishing the research of new drug with 8 categories and over 20 varieties, which contains gynaecology drug, muscle relaxants, antibiotics, cardiovascular and circulatory drug, antiviral, digestive system agent, psychotherapeutic agents, and antineoplastic drug etc. At present the ongoing projects contains 11 categories. Until now, we have possessed 15 patents, 3 provience/city hi-tech achievement.
Adamerck has truned to State Drug Administration for applying 2 national newly-invented first-class medicine with independent intellectual property rights in 2009, and we plan to apply the next 2 in this year. What’s more, in the next 10 years, Adamerck will keep on developing and applying over 10 national newly-invented first-class medicine.
The Blue Oxy which is a health supplements developed by Ademerck, has obtained the production validation from State Drug Administration, and now it truns into industrialization phase already. After the trail marketing by a model market, the sales of Blue Oxy is increasing constantly with a good prospects.
The further layout plan of Adamerck:
1. keeps on intensifying research baseof drug innovation, and develops over 10 national newly-invented first-class medicine with ndependent intellectual property rights in next 10 years;
2. keeps on intensifying research team and sale team;
3. cooperates with risk investment to come into the market; get various social supports in capital markets;
4. becomes one of the most growth potential company in China within 10 years, and relies on its core competency of innovation to become a international general medical group;
5. becomes the international pharmaceutical giants within 15 years.
Due to that pharmaceutical development is an important social program, Adameck hopes for more cooperative partner. Venture capital firm has its advantage on investment experience and fund operation, thus with the same bussiness objective, it will be the most ideal investor with additional value of us. We expect to bring in a top ranking management by venture capital, so as to promote our development ulteriorly.
|
|
|
|
